14
NPS Score
VS
Juno Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 6
- TOTAL
RATINGS
Merrimack Pharmaceuticals
- EMPLOYEE
PARTICIPANTS - 3
- TOTAL
RATINGS
Juno Therapeutics vs Merrimack Pharmaceuticals
Compare Juno Therapeutics versus Merrimack Pharmaceuticals for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 6 employees and customers of Juno Therapeutics and 3 employees and customers of Merrimack Pharmaceuticals.
Juno Therapeutics
Juno Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Juno Therapeutics.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Merrimack Pharmaceuticals. Their current market cap is $178.25M.
2.7/5
Product Quality
4/5
2.7/5
Pricing
5/5
2.7/5
Customer Service
5/5
| 57% | Promoters |
|---|---|
| 0% | Passive |
| 43% | Detractors |
100
NPS Score
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
Net Promoter Score
Winner by 86
See how Juno Therapeutics compares to its competitors
See how Merrimack Pharmaceuticals compares to its competitors
Working at Juno Therapeutics vs Working at Merrimack Pharmaceuticals
86 / 100
CEO Rating
Winner by 36%
50 / 100
CEO Rating
Juno Therapeutics
Juno Therapeutics doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Merrimack Pharmaceuticals
Employees at Merrimack Pharmaceuticals rate their CEO, Richard Peters, 50/100. This score is 36% lower than the scores of Juno Therapeutics' CEO, Hans Bishop.